Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - icatibant, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; glacial acetic acid - firazyr is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older with c1-esterase-inhibitor deficiency.

Israel - Tiếng Anh - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - icatibant as acetate - solution for injection - icatibant as acetate 10 mg/ml - icatibant - icatibant s.k. is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 -esterase-inhibitor deficiency.

Israel - Tiếng Anh - Ministry of Health

takeda israel ltd - icatibant as acetate - solution for injection - icatibant as acetate 30 mg / 3 ml - icatibant - icatibant - symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 -esterase-inhibitor deficiency.

Canada - Tiếng Anh - Health Canada

takeda canada inc - icatibant (icatibant acetate) - solution - 10mg - icatibant (icatibant acetate) 10mg - complement inhibitors

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

shire pharmaceuticals ltd - icatibant acetate - solution for injection - 10mg/1ml

Israel - Tiếng Anh - Ministry of Health

takeda israel ltd - icatibant as acetate - solution for injection - icatibant as acetate 30 mg / 3 ml - icatibant - symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 -esterase-inhibitor deficiency

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - icatibant acetate, quantity: 31.38 mg (equivalent: icatibant, qty mg) - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium hydroxide; water for injections - icaticip is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older with c1-esterase-inhibitor deficiency.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - icatibant acetate, quantity: 31.38 mg (equivalent: icatibant, qty mg) - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium hydroxide; water for injections - icazyr is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older with c1-esterase-inhibitor deficiency.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

multichem nz limited - icatibant acetate 10.46 mg/ml equivalent to icatibant 10 mg/ml - solution for injection - 30 mg/3ml - active: icatibant acetate 10.46 mg/ml equivalent to icatibant 10 mg/ml excipient: glacial acetic acid sodium chloride sodium hydroxide water for injection - indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older with c1-esterase-inhibitor deficiency.

Malta - Tiếng Anh - Medicines Authority

adalvo limited malta life sciences park, building 1, level 4 sir temi zammit san gwann industrial est, sgn 3000 san gwann, malta - icatibant - solution for injection in a pre-filled syringe - icatibant 10 mg/ml - other hematological agents